Literature DB >> 29924182

Persistent metabolic syndrome and risk of cardiovascular disease in children and adolescents.

Camilla Ribeiro Lima de Farias1, Carla Campos Muniz Medeiros1, Diogo Rodrigues Souza1, Ivelise Fhrideraid Alves Furtado da Costa1, Mônica Oliveira da Silva Simões1, Danielle Franklin de Carvalho1.   

Abstract

OBJECTIVE: to verify persistence of metabolic syndrome (MetS) and components in overweight children and adolescents, as well as its relation to socioeconomic and demographic characteristics and to the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) score.
METHOD: a two-point longitudinal study: at enrollment and after a 24-month interval, with 133 individuals ages from two to 18 years. The demographic anthropomorphic and blood variables were evaluated. Analysis was carried out by simple and paired association tests, as well as multiple logistic regression.
RESULTS: persistent MetS was observed in 38.3% of the sample, associated cardiovascular risk (ACR) in 79.7%, reduction in arterial pressure and do HDL-c. After adjusting for age and sex, excess weight (ExpB: 0.182; CI: 0.059-0.561), low HDL-c (ExpB: 9.247; CI: 1.157-73.930) and high LDL-c (ExpB:1.915; CI: 0.921-3.979) were associated with persistent MetS.
CONCLUSION: persistent MetS was associated with obesity, HDL-c and LDL-c, but not with the PDAY score.

Entities:  

Mesh:

Year:  2018        PMID: 29924182     DOI: 10.1590/0034-7167-2016-0564

Source DB:  PubMed          Journal:  Rev Bras Enferm        ISSN: 0034-7167


  2 in total

1.  Inflammatory Biomarkers and Components of Metabolic Syndrome in Adolescents: a Systematic Review.

Authors:  Ariane R de F Rocha; Núbia de S Morais; Silvia E Priore; Sylvia do C C Franceschini
Journal:  Inflammation       Date:  2021-09-21       Impact factor: 4.092

2.  Predictors of Lipid Profile Abnormalities Among Patients with Metabolic Syndrome in Southwest Ethiopia: A Cross-Sectional Study.

Authors:  Kassahun Haile; Admasu Haile; Abebe Timerga
Journal:  Vasc Health Risk Manag       Date:  2021-08-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.